Back to search

Article

Tivantinib induces mitotic death in SHH medulloblastoma cell lines.

2024-03-05

Abstract excerpt

The c-MET kinase signalling pathway is a key player in the development of the cerebellum and it has been identified as a potential therapeutic candidate for treating medulloblastoma. Here, we confirm that c-MET and its ligand HGF are highly expressed in the SHH medulloblastoma subgroup with SHH-α and SHH-β subtypes showing the highest levels of expression of both genes, respectively. HGF treatments and siRNA-media...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e64a78ee-1814-5773-9ab2-1f4bdfcebd61
DOI
10.21203/rs.3.rs-3937528/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Tivantinib induces mitotic death in SHH medulloblastoma cell lines.DOI 10.21203/rs.3.rs-3937528/v1
Select a neighboring publication to make it the new centre.